Blood Glucose Monitoring System (BGMS) Market Forecast 2024 to 2032
A Blood Glucose Monitoring System
(BGMS) is a comprehensive medical device designed to measure and monitor a
person's blood glucose levels, also known as blood sugar levels. It consists of
several components that work together to provide individuals with diabetes the
ability to regularly assess their blood glucose levels, enabling effective
diabetes management and prevention of complications. BGMSs are essential tools
for individuals with diabetes to monitor their condition and make informed
decisions about their treatment, diet, and lifestyle.
The Blood
Glucose Monitoring System (BGMS) Market was valued at USD 414.43Million in 2022
and is expected to register a CAGR of 4.92% by 2032.
Increased awareness about the
importance of blood glucose monitoring to prevent complications fuels the
demand for BGMS as vital components of diabetes self-care.
Key Company
•Roche
•LifeScan
•Abbott
•Ascensia
•ARKRAY
•I-SENS
•Omron
•B. Braun
•77 Elektronika
•AgaMatrix
•ALL Medicus
•Terumo
•Sinocare
•Yicheng
•Yuwell
•Acon
Market Segmentation (by Type)
•Blood Glucose Test Strips
•Blood Glucose Meter
Market Segmentation (by Application)
•Hospital
•Household
Comments
Post a Comment